The Discounted Cash Flow (DCF) valuation of Celldex Therapeutics Inc (CLDX) is (85.58) USD. With the latest stock price at 22.85 USD, the upside of Celldex Therapeutics Inc based on DCF is -474.5%.
Based on the latest price of 22.85 USD and our DCF valuation, Celldex Therapeutics Inc (CLDX) is a sell. selling CLDX stocks now will result in a potential gain of 474.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.5% | 6.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (308.51) - (51.29) | (85.58) |
| Upside | -1450.2% - -324.5% | -474.5% |